Skip to content
HowShorted

Tabula Rasa HealthCare, Inc. short interest in 2020

In 2020, Tabula Rasa HealthCare, Inc.'s disclosed short interest ran from 32.93% of shares outstanding on 15 Jan 2020 to 24.44% on 31 Dec 2020, a change of -8.49 percentage points. The year's high was 32.95% on 31 Jan 2020 and its low 21.95% on 30 Oct 2020, averaging 26.26% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 34.53 days on 31 Jul 2020. Full history: Tabula Rasa HealthCare, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Tabula Rasa HealthCare, Inc. in 2020

2020 in figures

Start of year
32.93% (15 Jan 2020)
End of year
24.44% (31 Dec 2020)
Change
-8.49 pp
High
32.95% (31 Jan 2020)
Low
21.95% (30 Oct 2020)
Average
26.26%
Highest days to cover
34.53 (31 Jul 2020)
SEC filings marked
8

Every report in 2020

Tabula Rasa HealthCare, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202032.93%26.35
31 Jan 202032.95%27.75
14 Feb 202032.39%29.09
28 Feb 202026.50%10.25results (8-K)
13 Mar 202025.01%16.4510-K filed
31 Mar 202026.36%14.87
15 Apr 202026.59%26.39
30 Apr 202025.10%20.34
15 May 202023.99%13.99results (8-K), 10-Q filed
29 May 202025.29%23.38
15 Jun 202027.22%23.39
30 Jun 202028.55%22.59
15 Jul 202029.45%24.37
31 Jul 202028.35%34.53
14 Aug 202025.55%9.01results (8-K), 10-Q filed
31 Aug 202025.81%25.42
15 Sep 202025.35%16.64
30 Sep 202024.32%18.66
15 Oct 202023.15%20.48
30 Oct 202021.95%24.85
13 Nov 202023.11%14.21results (8-K), 10-Q filed
30 Nov 202023.00%24.76
15 Dec 202022.90%22.45
31 Dec 202024.44%15.82

See also: Tabula Rasa HealthCare, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.